{"id":"https://openalex.org/W2013806387","doi":"https://doi.org/10.1185/03007995.2011.576236","title":"Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study","display_name":"Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study","publication_year":2011,"publication_date":"2011-05-10","ids":{"openalex":"https://openalex.org/W2013806387","doi":"https://doi.org/10.1185/03007995.2011.576236","mag":"2013806387","pmid":"https://pubmed.ncbi.nlm.nih.gov/21554144"},"language":"en","primary_location":{"id":"doi:10.1185/03007995.2011.576236","doi":"https://doi.org/10.1185/03007995.2011.576236","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2011.576236","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071142253","display_name":"Hind T. Hatoum","orcid":"https://orcid.org/0009-0000-2147-6954","observed_orcids":["https://orcid.org/0009-0000-2147-6954"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hind T. Hatoum","raw_affiliation_strings":["Hind T. Hatoum & Company and Pharmacy Administration, The University of Illinois at Chicago,\rIL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hind T. Hatoum & Company and Pharmacy Administration, The University of Illinois at Chicago,\rIL, USA","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047931838","display_name":"Swu\u2010Jane Lin","orcid":"https://orcid.org/0000-0003-0953-9988","observed_orcids":["https://orcid.org/0000-0003-0953-9988"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Swu-Jane Lin","raw_affiliation_strings":["Pharmacy Administration, The University of Illinois at Chicago and Hind T. Hatoum & Company,\rChicago IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Administration, The University of Illinois at Chicago and Hind T. Hatoum & Company,\rChicago IL, USA","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104015501","display_name":"Deborah A. Buchner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Buchner","raw_affiliation_strings":["Eisai Inc.,\rWoodcliff Lake, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc.,\rWoodcliff Lake, NJ, USA","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100728166","display_name":"Edward J. Kim","orcid":"https://orcid.org/0000-0002-8563-0823","observed_orcids":["https://orcid.org/0000-0002-8563-0823"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Kim","raw_affiliation_strings":["Former employee of Eisai Inc.,\rWoodcliff Lake, NY, USA","Former employee of Eisai Inc., Woodcliff Lake, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Former employee of Eisai Inc.,\rWoodcliff Lake, NY, USA","institution_ids":["https://openalex.org/I4210151718"]},{"raw_affiliation_string":"Former employee of Eisai Inc., Woodcliff Lake, NY, USA","institution_ids":["https://openalex.org/I4210151718"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5071142253"],"corresponding_institution_ids":["https://openalex.org/I39422238"],"apc_list":null,"apc_paid":null,"fwci":0.377,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.65368653,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"27","issue":"6","first_page":"1255","last_page":"1262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9200000166893005},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9929999709129333},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":1.0},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":1.0},{"id":"https://openalex.org/keywords/transfusion-dependence","display_name":"transfusion dependence","score":0.9300000071525574},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9779999852180481},{"id":"https://openalex.org/keywords/red-blood-cell-transfusion","display_name":"red blood cell transfusion","score":0.9110000133514404},{"id":"https://openalex.org/keywords/platelet-transfusion","display_name":"platelet transfusion","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.45899999141693115},{"id":"https://openalex.org/keywords/commercially-insured-patients","display_name":"commercially insured patients","score":0.8420000076293945},{"id":"https://openalex.org/keywords/treatment-initiation-timing","display_name":"treatment initiation timing","score":0.5569999814033508},{"id":"https://openalex.org/keywords/supportive-care","display_name":"supportive care","score":0.6079999804496765},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.3619999885559082},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.3529999852180481},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.3790000081062317},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9611714482307434},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.9509521722793579},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.928776741027832},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.923349916934967},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.7963178157806396},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.48947036266326904},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.48759549856185913},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47720867395401},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4173426926136017},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39638257026672363},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.09632948040962219},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.07808905839920044},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077209","descriptor_name":"Decitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001374","descriptor_name":"Azacitidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007345","descriptor_name":"Insurance Claim Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007345","descriptor_name":"Insurance Claim Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007345","descriptor_name":"Insurance Claim Review","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007995.2011.576236","doi":"https://doi.org/10.1185/03007995.2011.576236","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2011.576236","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:21554144","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21554144","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7300000190734863,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306571","display_name":"American Society of Hematology","ror":"https://ror.org/02nw48b86"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1855038159","https://openalex.org/W1970101456","https://openalex.org/W1979144446","https://openalex.org/W2000445173","https://openalex.org/W2031826516","https://openalex.org/W2036068780","https://openalex.org/W2052822682","https://openalex.org/W2071289131","https://openalex.org/W2076225806","https://openalex.org/W2077208257","https://openalex.org/W2081279521","https://openalex.org/W2083307780","https://openalex.org/W2099071696","https://openalex.org/W2106584820","https://openalex.org/W2149982846","https://openalex.org/W2155296700","https://openalex.org/W2316392947","https://openalex.org/W2399266602","https://openalex.org/W2418357856","https://openalex.org/W4242962945","https://openalex.org/W4247972768"],"related_works":["https://openalex.org/W2054507167","https://openalex.org/W3203236595","https://openalex.org/W2409251897","https://openalex.org/W1983754555","https://openalex.org/W2051650123","https://openalex.org/W2559444916","https://openalex.org/W2436188093","https://openalex.org/W2096084875","https://openalex.org/W4245640489","https://openalex.org/W2557741488"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,163],"purpose":[2],"of":[3,10,20,34,98,120,140,149,165,187,225,241,274,285,292,306],"this":[4],"study":[5,52,294],"is":[6],"to":[7,16,28,90,116,192,356],"describe":[8],"patterns":[9],"hypomethylating":[11],"agents":[12,36],"(HMA)":[13],"use":[14,33,273,284],"and":[15,23,31,82,93,104,123,159,174,219,250,282,300],"compare":[17,91],"treatment":[18,38,226,261,338],"outcomes":[19],"decitabine":[21],"(DAC)":[22],"azacitidine":[24],"(AZA)":[25],"with":[26,42,71,145,239,262,288,335,339,343,348,353],"respect":[27],"transfusion":[29],"dependence":[30],"the":[32,141,172,185,199,204,293,296,301,304,354],"erythropoiesis-stimulating":[35],"(ESA)":[37],"in":[39,198,203,232,327],"commercially-insured":[40],"patients":[41,62,142,221,247,269,307,333],"Myelodysplastic":[43],"Syndromes":[44],"(MDS).":[45],"RESEARCH":[46],"DESIGN":[47],"AND":[48],"METHODS:":[49],"A":[50],"retrospective":[51],"using":[53,264],"MarketScan":[54],"Research":[55],"Data,":[56],"a":[57,146],"large":[58],"claims":[59,75],"database":[60],"studied":[61],"who":[63],"received":[64,222],"DAC,":[65],"AZA,":[66,235],"or":[67,126],"Supportive":[68],"Care":[69],"(SC)":[70],"at":[72],"least":[73],"two":[74],"for":[76,108,132,246,253,323,325,358],"MDS":[77,190,332],"between":[78,171],"January":[79],"1,":[80],"2006":[81],"December":[83],"31,":[84],"2008.":[85],"Poisson":[86,265],"regressions":[87],"were":[88,143,156,308],"used":[89],"DAC":[92,200,233,249,340],"AZA":[94,180,205,256,349],"on":[95],"post-index":[96],"number":[97,119,186,224],"red":[99],"blood":[100],"cell/platelet":[101],"(RBC/PLT)":[102],"transfusions":[103,276,346],"ESA":[105,127],"treatment,":[106],"controlling":[107],"age,":[109],"gender,":[110],"Charlson":[111],"Comorbidity":[112],"Index":[113],"(CCI),":[114],"time":[115],"HMA":[117,121,193,263],"initiation,":[118],"cycles,":[122],"pretreatment":[124],"RBC/PLT":[125,275],"claims.":[128],"No":[129],"other":[130],"adjustment":[131],"disease":[133,328,359],"severity":[134,360],"was":[135,196,341],"made.":[136],"RESULTS:":[137],"Approximately":[138],"48%":[139],"males":[144],"mean":[147],"age":[148],"73":[150],"years":[151],"(N":[152],"=":[153,178,181,215,258,280],"2525).":[154],"There":[155],"37":[157],"DAC-treated":[158,268],"60":[160],"AZA-treated":[161,175,220,289],"patients.":[162,290],"length":[164],"follow-up":[166],"did":[167,320],"not":[168,321],"significantly":[169,271],"differ":[170],"DAC-":[173,218],"groups":[176],"(DAC":[177],"349.2;":[179],"350.5":[182],"days);":[183],"however,":[184],"days":[188,209,243,252],"from":[189],"diagnosis":[191],"therapy":[194],"initiation":[195],"longer":[197],"cohort":[201,206],"than":[202,347],"(mean":[207],"93.7":[208],"vs.":[210,230,234],"50.8":[211],"days,":[212],"respectively,":[213],"p":[214,236,279],"0.029).":[216],"Both":[217],"similar":[223,283],"cycles":[227],"(mean:":[228],"4.8":[229],"5.6":[231],">":[237],"0.05),":[238],"means":[240],"4.6":[242],"per":[244],"cycle":[245],"receiving":[248,255],"7.4":[251],"those":[254],"(p":[257],"0.003).":[259],"Following":[260],"regression":[266],"analysis,":[267],"had":[270],"lower":[272],"(RR":[277],"0.206,":[278],"0.034)":[281],"ESAs":[286],"compared":[287],"Limitations":[291],"included":[295],"small":[297],"sample":[298],"size,":[299],"fact":[302],"that":[303],"majority":[305],"unspecified":[309],"regarding":[310],"their":[311],"International":[312],"Prognostic":[313],"Scoring":[314],"System":[315],"(IPSS)":[316],"risk":[317],"category,":[318],"which":[319],"allow":[322],"accounting":[324],"differences":[326],"severity.":[329],"CONCLUSIONS:":[330],"In":[331],"treated":[334],"an":[336],"HMA,":[337],"associated":[342],"less":[344],"frequent":[345],"treatment.":[350],"Further":[351],"studies":[352],"ability":[355],"control":[357],"are":[361],"warranted.":[362]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}